Series A funding round for Eikon Therapeutics raising $150M in May 2021
Series A funding round for Eikon Therapeutics raising $150M in May 2021
| Investor | Firm Type | Partner |
|---|
The Column GroupLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Jack Leeney | |
| Angel | Carol Gallagher | |
| Angel | Kevin Ding | |
| Angel | Boris Hageney |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$1.1B
Top Valuation
-
Eikon Therapeutics raised $150M in a Series A round.
The round was announced on 05/01/21.
The round was led by The Column Group.